Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • nct (2)
Country
  • Austria (2)
  • Finland (2)
  • France (2)
  • Germany (2)
  • Italy (2)
  • Korea, Republic of (2)
  • Norway (2)
  • Spain (2)
  • Sweden (2)
  • Taiwan, Province of China (2)
  • United States (2)
  • Australia (1)
  • Belgium (1)
  • Canada (1)
  • Croatia (1)
  • Czech Republic (1)
  • Estonia (1)
  • Hungary (1)
  • Israel (1)
  • Latvia (1)
  • Lithuania (1)
  • Netherlands (1)
  • Poland (1)
  • Romania (1)
  • Russian Federation (1)
  • Slovakia (1)
  • Ukraine (1)
  • United Kingdom (1)
Source
  • nct (2)
Phase
  • complete (1)
  • terminated (1)

Country: Italy,Korea, Republic of,Austria,Germany,Sweden,Spain,Norway
nct Update Il y a 5 ans

A Study of Tasisulam Versus Paclitaxel as Treatment for Metastatic Melanoma The primary purpose of this study is to see how tasisulam affects metastatic melanoma when compared against paclitaxel as measured by overall survival.

  • Country Australia, Austria, Belgium, Canada, Finland, France, Germany, Israel, Italy, Korea, Republic of, Netherlands, Norway, Poland, Spain, Sweden, Taiwan, Province of China, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information
nct Update Il y a 5 ans

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension The objective of the current study is to investigate the safety and efficacy of BI 10773 in 2 different doses compared to Metformin or to Sitagliptin given for 78 weeks in different modalities of treatment in patients with type 2 diabetes mellitus.

  • Country Austria, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Norway, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Province of China, Ukraine, United States,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.